A Gathering: The Project Santa Fe Foundation Lab 2.0 Movement
Clinical Lab 2.0
The global movement of evolving the clinical lab from test volume to lab value.
We extend to you our great thanks for gathering together October 2-4, 2024 in Plymouth, MI for the Project Santa Fe Foundation Fall 2024 Colloquium.?Taking advantage of ideas presented during our colloquium, we put before you the following thoughts.
"Three Questions" ?
1. How to tell the right time for every deed? ? 2. How to know who are the most essential people? 3. How to decide which pursuits are the most important? —Leo Tolstoy
The Project Santa Fe Foundation Lab 2.0 movement emerges during a crucial juncture in our global health narrative—a time demanding reflection and action toward sustainable healthcare. As we navigate the complexities of modern healthcare, we are called to explore the vital role of clinical laboratories in this transformation.
In redefining our approach, we aim to answer the pressing questions posed by Tolstoy: understanding the right timing for impactful actions, recognizing the essential stakeholders in our community, and prioritizing initiatives that will shape a sustainable future. By integrating these principles, clinical labs can evolve into pivotal players in promoting health equity and environmental responsibility.
The Clinical Lab 2.0 movement invites healthcare professionals, researchers, and community advocates to participate in a collaborative dialogue. By sharing insights and experiences, we can collectively identify the most pressing health challenges and the innovative solutions needed to address them. The role of clinical labs extends beyond diagnostics; they can serve as beacons of change, driving initiatives that prioritize both patient care and ecological sustainability.
A Gathering, of which the Fall 2024 Colloquium is a stunning example, showcases the efforts of this movement—moments of insight and inspiration that challenge us to reflect on our current practices and envision a more sustainable future. Each initiative represents a unique opportunity to engage with the community, sparking discussions that can lead to meaningful change.
Ultimately, a call to action. This is an invitation to all to continue forward: come together, bring your talents and energy to the tasks at hand, and help us chart the course forward. How can clinical labs effectively respond to the evolving needs of healthcare? What collaborations will ensure that we prioritize the most important pursuits for a healthier planet? Let us continue this journey together, as we seek to redefine the role of clinical laboratories in building a sustainable healthcare future.
With our deep appreciation,
Khosrow and Jim
领英推荐
Board of Directors:
Khosrow R. Shotorbani, MBA, MT(ASCP) President, and CEO Project Santa Fe Foundation
James M. Crawford, MD, PhD Chair of The Board, Professor and Chair Emeritus, Department of Pathology and Laboratory Medicine, Northwell Health
Myra L. Wilkerson, MD Board Treasurer, Division of Laboratory Medicine, Geisinger Health System
Mark K. Fung, MD, PhD Professor and Vice Chair Population Health, Department of Pathology and Laboratory Medicine, The Robert Larner MD College of Medicine, University of Vermont
Karen L. Kaul, MD, PhD Duckworth Family Chair of Molecular Pathology, Chair Pathology and Laboratory Medicine, Northshore University Healthsystem; Clinical Professor of Pathology, University of Chicago Pritzker School of Medicine
Octavia M. Peck Palmer, PhD Immediate Past President of ADLM, Vice Chair of Health Equity, Division Director, Clinical Chemistry, Associate Professor of Pathology, University of Pittsburgh Medical Center
Nancy Stratton, MBA Chief Executive Officer of COLA Inc.
Richard J. Zarbo, MD, DMD Senior VP and Chair, Pathology and Laboratory Medicine, Henry Ford Health System